These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17704094)

  • 1. Treatment of anaemia in chronic heart failure--optimal approach still unclear.
    Murphy NF; McDonald K
    Eur Heart J; 2007 Sep; 28(18):2185-7. PubMed ID: 17704094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anemia as complication of chronic heart failure: prevalence, treatment, prognosis].
    Tereshchenko SN; Atroshchenko ES; Uskach TM; Kudinova AA; Riabinina MN
    Ter Arkh; 2008; 80(9):90-5. PubMed ID: 19555048
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of erythropoietin in heart failure management.
    Caiola K; Cheng JW
    Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darbapoetin alfa does not help adults with heart failure and anaemia.
    BMJ; 2013 Mar; 346():f1626. PubMed ID: 23487165
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaemia of chronic disease in chronic heart failure: the emerging evidence.
    Okonko DO; Van Veldhuisen DJ; Poole-Wilson PA; Anker SD
    Eur Heart J; 2005 Nov; 26(21):2213-4. PubMed ID: 16204265
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia in chronic heart failure: etiology and treatment options.
    Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
    Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and heart failure: the end of a promise?
    Kleijn L; Westenbrink BD; van der Meer P
    Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
    [No Abstract]   [Full Text] [Related]  

  • 9. Further aspects of anemia, heart failure, and erythropoietin.
    Kovacic JC
    J Am Coll Cardiol; 2005 May; 45(9):1549-50; author reply 1550-1. PubMed ID: 15862435
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythropoietin in the treatment of heart failure and ischemia].
    Lewartowski B
    Kardiol Pol; 2007 Feb; 65(2):192-7. PubMed ID: 17366366
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodilution is a mechanism of anaemia in patients with heart failure: reply.
    Westenbrink BD; Kleijn L; van der Meer P
    Eur J Heart Fail; 2013 Sep; 15(9):1075-6. PubMed ID: 23960086
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there an optimal hematocrit value for cardiac patients?
    Cheng TO
    J Am Coll Cardiol; 2005 May; 45(9):1549; author reply 1550-1. PubMed ID: 15862436
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodilution is a mechanism of anaemia in patients with heart failure.
    Prakash ES
    Eur J Heart Fail; 2013 Sep; 15(9):1074. PubMed ID: 23883650
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries of nursing care-related systematic reviews from the Cochrane library: erythropoiesis-stimulating agents for anemia in chronic heart failure patients.
    Barrett D
    J Cardiovasc Nurs; 2010; 25(5):381-2. PubMed ID: 20714234
    [No Abstract]   [Full Text] [Related]  

  • 15. Anemia in heart failure: marker or mediator of adverse prognosis?
    Levy WC
    J Am Coll Cardiol; 2008 Feb; 51(5):577-8. PubMed ID: 18237688
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anaemia, cardiac failure and erythropoietin].
    Cohen Solal A; Beauvais F
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):997-1001. PubMed ID: 16294546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?
    Kleijn L; de Boer RA; Voors AA
    Eur J Heart Fail; 2010 Mar; 12(3):215-6. PubMed ID: 20156936
    [No Abstract]   [Full Text] [Related]  

  • 18. The cardio-renal anemia syndrome.
    Iaina A; Silverberg DS; Wexler D; Iaina Nomy L
    Med Pregl; 2007; 60 Suppl 2():145-50. PubMed ID: 18928182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in the therapeutic use of erythropoiesis stimulating agents.
    Jelkmann W
    Br J Haematol; 2008 May; 141(3):287-97. PubMed ID: 18410567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome.
    Leszek P; Kruszewski M
    Am Heart J; 2008 Mar; 155(3):e25; author reply e19. PubMed ID: 18294469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.